Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Fibrinogen Concentrate (Human) (FCH) for On-demand Treatment of Acute Bleeding in Subjects With Congenital Fibrinogen Deficiency

NCT00916656 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.

NCT NCT00916656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00916656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Fibrinogen Concentrate (Human) (FCH) for On-demand Treatment of Acute Bleeding in Subjects With Congenital Fibrinogen Deficiency
Lead sponsor
CSL Behring
Phase
Phase 3
Overall status
Withdrawn
Start date
October 31, 2009
Completion date
March 31, 2014
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

afibrinogenemia, fibrinogen deficiency, hypofibrinogenemia